Comparative 1-year outcomes of dofetilide vs amiodarone for atrial fibrillation in hypertrophic cardiomyopathy: a propensity-matched study

13 April 2026 (09:04 - 09:12)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation miscellaneous Rhythm Control, Antiarrhythmic Drugs EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

ESC 365 is supported by

ESC 365 is supported by